If BRAF V600E mutations are present in MSI-H tumours, the possibility of LS can be nearly excluded, but only approximately 40–50% of MSI-H sporadic CRC tumours are reported to have BRAF mutations (Wang et al, 2003). The gene discussed is BRAF; the disease is neoplasm.